Quick Takeaways
- Heidi Fields has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $7,230,895.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Heidi Fields
- Location
- Santa Clara, CA
- Summary
- The estimated net worth of Heidi Fields is at least $7,230,895 dollars as of 05 Jun 2025. Heidi Fields is the Director of AGILENT TECHNOLOGIES, INC. and owns shares of AGILENT TECHNOLOGIES, INC. (A) stock worth about $7.13M. Heidi Fields is the Director of Phathom Pharmaceuticals, Inc. and owns shares of Phathom Pharmaceuticals, Inc. (PHAT) stock worth about $99.3K.
- Signature
- /s/ Steven Basta, Attorney-in-Fact for Heidi Fields
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Heidi Fields and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: AGILENT TECHNOLOGIES, INC. ($7,131,595).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Heidi Fields
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| A | AGILENT TECHNOLOGIES, INC. | Director | $7,131,595 | 14 Mar 2025 | ||
| PHAT | Phathom Pharmaceuticals, Inc. | Director | $99,300 | 03 Jun 2025 | ||
| ICVX | Icosavax, Inc. | Former Director | $0 | 19 Feb 2024 |
Insider Transactions Reported by Heidi Fields:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.